Relugolix Combo Therapy Beneficial for Fibroid-Related Menorrhagia

THURSDAY, Feb. 18, 2021 -- For patients with uterine fibroids, once-daily relugolix combination therapy results in significantly reduced menstrual bleeding compared with placebo, according to a study published in the Feb. 18 issue of the New England...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news